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SUPPLEMENTARY INFORMATION

Figure S1. The spindle assembly checkpoint is activated in CDK11 depleted cells
(A) Western blot showing the levels of BubR1 protein in control (lane C) and CDK11 RNAi treated (lane R) cells. The asterisk indicates a higher molecular weight, putative phosphorylated band that is characteristic of checkpoint activation. (B) CDK11 RNAi treated cells retain BubR1 at their kinetochores. In control cells BubR1 associates with unattached or newly attached kinetochores (1: prophase, 2: prometaphase) but is no longer detectable at metaphase (3). Bipolar spindles often fail to form following CDK11 knock down and the kinetochores retain their BubR1 staining (4). Bar is 10 µm.

Figure S2. Plk1 and Aurora A protein levels in control and CDK11 RNAi treated cells. 
A Western blot showing -tubulin (top), Plk1 (middle) and Aurora A (bottom) protein levels in control and CDK11 RNAi cell extracts. Knock down of CDK11 causes cells to arrest and accumulate in mitosis resulting in increased amounts of Aurora A and Plk1.  β-tubulin levels are unaffected following treatment and serve as a loading control. 

Figure S3. Centrosomal recruitment of Plk1 is compromised  in CDK11 depleted cells.
Relative quantification of Plk1 immunofluorescence signal intensity at the centrosome in control (black) and CDK11 RNAi treated cells (grey).  CDK11 knock down dramatically diminishes  the amount of Plk1 recruited to the centrosome irrespective of the stage of spindle formation or time spent in mitosis (note that the Plk1 signal intensity of monopolar spindles, which are marked by hyper-condensed chromosomes and a prolonged arrest, are no higher than those observed in prophase CDK11 depleted cells).

Figure S4. Localisation of GFP-CDK11p110 during the cell cycle.
GFP-CDK11p110 (green and monochrome in lower panels) is almost entirely nuclear during interphase, where it is seen as nuclear aggregates. In dividing cells the protein becomes cytoplasmic until telophase when it accumulates in restitution nuclei.  At no time does GFP-CDK11p110 co-localise with the centrosomes labelled with an anti-Pericentrin antibody (red in merge panels and monochome in middle panels). Bar is 10 m.

Figure S5. Neither of the mitotic Cyclins A, B or Cyclin L associates with the GFP-CDK11p58 mitotic protein kinase.  Active GFP-CDK11p58 was immunoprecipitated from mitotic cells and analysed by Western blot.  The samples were challenged with antibodies against CDK11, Cyclin A, Cyclin B and Cyclin L.  As shown in the right hand blot, none of these Cyclins were detected and thus do not associate with CDK11p58.

Video 1. Movie of a control HeLa cell expressing GFP-tagged -tubulin three days after control RNAi






















The following primers were used for the second amplification to generate EcoRI and XhoI restriction sites (underlined) for cloning:
GFP-CDK11p110:
5’ AACTCGAGATGGGTGATGAAAAGGACTC 3’ (XhoI)
5’ AAGAATTCTGACCTTCAGAACTTGAGGC 3’ (EcoRI)

GFP-CDK11p58:
5’ AACTCGAGGCGAGTGAAGATGAAGAACG 3’ (XhoI)
5’ AAGAATTCTGACCTTCAGAACTTGAGGC 3’ (EcoRI)

The PCR products were cloned into pEGFP-C3 (CLONTECH) to generate the pEGFP-CDK11p58 and pEGFP-CDK11p110 vectors.

To generate recombinant MBP-CDK11p58, the sequence of CDK11p58 was amplified by PCR from the vector mut-p110PITSLRE using the following primers to also insert restriction sites: 5’AAGAATTCGCGAGTGAAGATGAAGAACG3’ (EcoRI) and 5’AATCTAGATGACCTTCAGAACTTGAGGC 3’ (XbaI). The PCR product was cloned into pMal-c2E (BioLabs) using EcoRI and XbaI restriction sites. The fusion protein has the MBP (Maltose Binding Protein) fused to the amino-terminal end of CDK11p58.

Interference RNA
Human CDK11 siRNA oligonucleotides (sequence 5’-AGCGGCUGAAGAUGGAGAA-3’, which targets CDK11 mRNA and consequently abolish the translation of both p58 and p110 isoforms) was purchased from EUROGENTEC. A random siRNA was used as a control. siRNAs were transfected into cells using oligofectamine following the manufacturer’s instructions (Invitrogen, Life technologies). Each experiment was repeated at least three times and 100 mitotic figures were scored for each experiment.

Generation of GFP-CDK11p110 and GFP-CDK11p58 Cell Lines
Stable cell lines were generated introducing the relevant construct into a 10-cm dish of HeLa cells by using calcium phosphate-mediated transfection. After 24 h, cells were washed and incubated in selective media containing G418 (500 g/ml; Invitrogen) during 14 days. Thereafter, cells were transferred into individual wells of a 96-well plate with 1 cell by well and selective medium added during two weeks. Individual clones were expanded in selective media before testing for protein expression by Western blotting and fluorescence microscopy.

Production of a recombinant protein MBP-CDK11p58 
MBP-CDK11p58 recombinant protein expression was induced with 1mM IPTG in competent E. coli BL21 (DE3) cells (NOVAGEN). Cells were harvested by centrifugation and stored at –80°C in Extract Buffer (80 mM Tris-HCl, pH 7.4, 0.8 M, 0.2 % Tween-20, 1 mM PMSF, 1 mM DTT). Chromosomal DNA was sheared by passage through a 23-gauge needle before centrifugation for 30 min at 10 000 g. The supernatant was then diluted three times with Washing Buffer (20 mM Tris-HCl, pH 7.4, 200 mM NaCl, 0.1% Tween-20, 1 mM DTT). The MBP-CDK11p58 was purified on an amylose resin column (BioLabs) and elution was performed in a buffer containing 20 mM Tris-HCl, pH 7.4, 200 mM NaCl, 1 mM DTT, 10 mM Maltose. The protein was dialysed overnight in PBS at 4°C and used for rabbit immunisation.

Western blotting and Immunofluorescence Analyses
Western blots were performed according to standard procedures.
Anti-CDK11 antibody (which reacts with both CDK11p110 and CDK11p58) was obtained after rabbit immunisation against the recombinant protein MBP-CDK11p58. This antibody was affinity-purified on a nitrocellulose membrane and used at concentration of 100 ng/ml for Western blotting and at 600 ng/ml for immunofluorescence analysis.  Other primary antibodies for either Western blots or immunofluoresence and their working concentrations were; mouse anti--tubulin (1/2000, clone 2.1, Sigma Chemicals), mouse anti--tubulin (1/2000, clone GTU-88, Sigma Chemicals), mouse anti-Plk (Polo-like kinase) antibody cocktail (2 g/ml, Zymed laboratories), mouse anti-BubR1 (250 ng/ml, BD Transduction Laboratories), mouse anti-Aurora-A (1/500, described previously)(Cremet et al., 2003), rabbit anti-Phospho-Histone H3 (100 ng/ml, Euromedex), mouse monoclonal anti-CDK11(clone 9B3, gift of Dr Kidd, dilution 1/1000) and mouse anti-GFP (2 g/ml, clones 7.1 and 13.1, ROCHE). Proteins were visualised using commercially available secondary antibodies and the ECL chemi-luminescent reagent (Pierce) for Western blots.
To quantify Western blot protein levels phosphatase-conjugated secondary antibodies were used (Jackson ImmunoResearch) and visualised with the ECF reagent (Amersham Biosciences). Quantification of CDK11 fluorescence signal on the nitrocellulose membrane was performed using the Storm840 apparatus (Molecular Dynamics) using the ImageQuant software and -tubulin as a loading control.
For immunoflouresence analysis cells were grown on glass coverslips and fixed using either of two protocols. In the first, samples were fixed for 10 min at room temperature (RT) with 75% methanol, 3.7% formaldehyde and 0.5x PBS and then washed 2 minutes with PBS containing 0.1% Triton X-100. Under the second fixation method, cells were immersed in – 20°C methanol for 10 min. Cells were blocked for1 hour in PBS containing 3% BSA (PBST-BSA) before being incubated overnight at 4°C in primary antibodies diluted in PBST-BSA. Secondary antibodies were applied for 1 to 2 hours at RT. Coverslips were mounted in Vectashield containing DAPI (Vector Laboratories), which also stains the DNA.  Samples were viewed with a Leica DMIRE2 inverted confocal microscope or Leica DMRXA2 fluorescent microscope with a 63x (N.A. 1.32) lens and equipped with standard fluorescence filters. Images were acquired with a CoolSnapHQ camera (Roper Scientific) using Metamorph software (Universal Imaging) and prepared as single sections or maximum intensity projections before being processed in Photoshop 7.0 (v. 7.0; Adobe).

Immunoprecipitation and kinase assays.
 




Image acquisition and relative quantification of -tubulin and Plk1 signal at the centrosome
To compare fluorescence intensities at the centrosome, cells were fixed and stained as above. An initial image acquisition time was empirically determined that kept the signal intensity of the centrosome within the dynamic range of the camera. All subsequent experiments used that exposure time.  Because the centrosome can be modelled as a sphere that is approximately 1,5 µm in diameter we optically sectioned this organelle at 0,3 µm steps.  Z-steps were then turned into projections and the average centrosomal intensity after background subtraction was determined. All intensity comparisons were determined from at least 10 different cells to minimise cell-to-cell staining variations. Calibrated fluorescent beads (Molecular probes) were used in the mounting media as internal control to minimise the variation between different samples
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